Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 12/20 | 0.44 |
| ▸ | CCKBR | P32239 | 6/20 | 0.43 |
| ▸ | CCKAR | P32238 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9040407 | 0.81 | CCKBR (0.44) | SCN9ACCKBRCCKAR | |
| SCHEMBL28513980 | 0.78 | PSEN1 (0.46) | SCN9AKMT2AL3MBTL1 | |
| SCHEMBL19224503 | 0.74 | NFKB1 (0.51) | SCN9ACCKBRCCKARKMT2AL3MBTL1 | |
| SCHEMBL19207684 | 0.74 | NFKB1 (0.51) | SCN9ACCKBRCCKARKMT2AL3MBTL1 | |
| SCHEMBL9042321 | 0.74 | CCKBR (0.58) | CCKBR | |
| SCHEMBL7808673 | 0.72 | SCN9A (0.52) | SCN9ACCKBRCCKARNFKB1NFKB2 | |
| SCHEMBL4413008 | 0.71 | PSEN1 (0.52) | SCN9ACCKBRCCKAR | |
| SCHEMBL4705050 | 0.71 | SCN9A (0.64) | SCN9ACCKBRCCKARKMT2AL3MBTL1 | |
| SCHEMBL14019266 | 0.71 | SCN9A (0.64) | SCN9ACCKBRCCKARKMT2AL3MBTL1 | |
| SCHEMBL12345861 | 0.71 | SCN9A (0.64) | SCN9ACCKBRCCKARKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0703222-A1 | 3-AMINOAZEPINE COMPOUND AND PHARMACEUTICAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-03-27 | — | — | EP | disclosed |